"Guidelines management knee osteoarthritis Whom what" Channels RSS

21:24 EST 28th November 2014 | BioPortfolio

BioPortfolio's Channels offers visitors a single point of access to life science and healthcare subjects, technologies, products and services. For example ImmTAC developed by Immunocore, PolyXen developed by Xenetic Biosciences. Each dedicated Channel web page provides highly specific information sourced from BioPortfolio's unique collection of databases - news stories, corporate directory, clinical trials, medical and scientific information.

Organizations can request specific channel pages to be created to promote their products, technologies, research tools and services. BioPortfolio makes a nominal charge of between $40 to $50 per web page published. Each bespoke Channel page is managed by the registered member who can edit and amend over the 12 month subscription period. To start publishing content on BioPortfolio's Channels open http://www.bioportfolio.net/report/23346-biochannel-publish-content-on-products-technologies.html

Interested? Contact priority@bioportfolio.com

Showing "Guidelines management knee osteoarthritis Whom what" Channels 1–25 of 35

Relevant

Knee

Osteoarthritis OA

Osteoarthritis of the Hand

Management of complications

Pain management

Perioperative Management

Management of acute infection

Management of Adverse Effects

Management of autonomic dysfunction

Management of muscle spasm

Self-Management

Self-management is quite a new idea in healthcare, and it is for patient with long-term conditions to regain some control over their life, and to be able lead a better life,  despite their health problems. Self-management techniques focus on diet, e...

Probably Relevant

Management Forum - highest quality conference, seminar and knowledge-based experiences

Since 1983, Management Forum have built a reputation on providing the highest quality conference, seminar and knowledge-based experiences for leading professionals in some of the world's most demanding industries. Based in Woking, Surrey, UK, Ma...

O2PR

O2PR is a specialist PR and communications consultancy providing bespoke services to public and private sector organisations operating in the fields of science, engineering and technology. The development and implementation of creative print, broadcas...

Veregen

Veregen® is an ointment used to treat external genital warts. In the USA, Germany, Austria, Spain, Switzerland and Serbia, Veregen® is already marketed by our partners. Sales and marketing partnerships are also in place for this drug in a large n...

Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs of an affected individual. The symptoms of PAH are non-specific and can range from m...

Vancomycin

Vancomycin is an antobiotic indicated for the treatment of serious, life-threatening infections by Gram-positive bacteria that are unresponsive to other less-toxic antibiotics. In particular, vancomycin should not be used to treat methicillin-sensitive S...

Boston Scientific

Boston Scientific is a global medical device company, the 8th largest (based on annual sales, which were over $8 billion in 2010). It is the world's second largest maker of heart devices; products of note include Taxus Express stent and Cognis card...

PATHSEEK

Sequencing platforms in diagnostic laboratories may aid both patient management by detecting resistance associated mutations, and public health measures, by determining phylogenetic relationships between infections from different patients. Current platfo...

UroGenRA - Genitourinary cancer array

UroGenRA is a CGI custom-designed oligonucleotide array for implementation within a clinical laboratory as an array CGH-based diagnostic/prognostic tool for kidney, prostate, and bladder cancers. It was designed to detect gains and losses that frequently...

Possibly Relevant

Rivaroxaban

Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across the venous arterial thromboembolic (VAT) space: The ...

GE Healthcare

Ranked as the third largest medical device company in the world (based on annual sales), GE Healthcare generates $16 billion in sales each year. GEs' area of expertise is the imaging that is integral to so many medical specialties, including cardio...

Medtronic

With annual sales reaching $15 billion in 2010, Medtronic is the 4th largest medical devices company in the world (based on annual sales). The device portfolio of Medtronic is broad; covering cardiovascular stents, defibrillators and pacemakers, diabet...

Transforming growth factor beta TGF beta

Transforming growth factor-beta (TGF-beta) family members are secreted multifunctional cytokines that play pivotal roles in development and disease. The prototypic member of this family, TGF-beta, plays a dual role in carcinogenesis, acting as a tumor supp...

Sweden

The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of funds from the European Federation of Pharmaceutical Indus...

Health IT Information Technology

Why Health IT?   Health information technology (Health IT) makes it possible for health care providers to better manage patient care through secure use and sharing of health information - especially through the comprehensive management of health...


Search BioPortfolio:
Loading
Advertisement
Advertisement

Channels Quicklinks